Yungjin Pharm.
003520.KO
1.85 USD
-0.02
-1.07%
y
Overview
Last close
1.85 usd
Market cap
338.69M usd
52 week high
2.25 usd
52 week low
1.45 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.9371
Price/Book Value
5.0799
Enterprise Value
377.61M usd
EV/Revenue
2.073
EV/EBITDA
34.8222
Key financials
Revenue TTM
115.31M usd
Gross Profit TTM
49.95M usd
EBITDA TTM
10.52M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
235.66B usd
Net debt
N/A usd
About
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm. Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.
- Symbol003520.KO
- ExchangeKO
- IsinKR7003520004
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEO
- HeadquarterSeoul
- Web sitehttps://www.yungjin.co.kr
